These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 24155778)

  • 21. Association between cisplatin resistance and mutation of p53 gene and reduced bax expression in ovarian carcinoma cell systems.
    Perego P; Giarola M; Righetti SC; Supino R; Caserini C; Delia D; Pierotti MA; Miyashita T; Reed JC; Zunino F
    Cancer Res; 1996 Feb; 56(3):556-62. PubMed ID: 8564971
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Downregulation of miR-130a contributes to cisplatin resistance in ovarian cancer cells by targeting X-linked inhibitor of apoptosis (XIAP) directly.
    Zhang X; Huang L; Zhao Y; Tan W
    Acta Biochim Biophys Sin (Shanghai); 2013 Dec; 45(12):995-1001. PubMed ID: 24145606
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trichostatin A up-regulates p73 and induces Bax-dependent apoptosis in cisplatin-resistant ovarian cancer cells.
    Muscolini M; Cianfrocca R; Sajeva A; Mozzetti S; Ferrandina G; Costanzo A; Tuosto L
    Mol Cancer Ther; 2008 Jun; 7(6):1410-9. PubMed ID: 18566213
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ubiquitin Carboxyl-Terminal Hydrolase L1 (UCHL1) Promotes Uterine Serous Cancer Cell Proliferation and Cell Cycle Progression.
    Kwan SY; Au-Yeung CL; Yeung TL; Rynne-Vidal A; Wong KK; Risinger JI; Lin HK; Schmandt RE; Yates MS; Mok SC; Lu KH
    Cancers (Basel); 2020 Jan; 12(1):. PubMed ID: 31906456
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ABCF2, an Nrf2 target gene, contributes to cisplatin resistance in ovarian cancer cells.
    Bao L; Wu J; Dodson M; Rojo de la Vega EM; Ning Y; Zhang Z; Yao M; Zhang DD; Xu C; Yi X
    Mol Carcinog; 2017 Jun; 56(6):1543-1553. PubMed ID: 28112439
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cisplatin- and paclitaxel-induced apoptosis of ovarian carcinoma cells and the relationship between bax and bak up-regulation and the functional status of p53.
    Jones NA; Turner J; McIlwrath AJ; Brown R; Dive C
    Mol Pharmacol; 1998 May; 53(5):819-26. PubMed ID: 9584207
    [TBL] [Abstract][Full Text] [Related]  

  • 27. UCHL1 promotes the proliferation of porcine granulosa cells by stabilizing CCNB1.
    Shi S; Yuan H; Zhang L; Gao L; Zhao L; Zeng X; Qiao S; Chu G; Cai C
    J Anim Sci Biotechnol; 2024 Jun; 15(1):85. PubMed ID: 38858680
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cisplatin-induced apoptosis proceeds by caspase-3-dependent and -independent pathways in cisplatin-resistant and -sensitive human ovarian cancer cell lines.
    Henkels KM; Turchi JJ
    Cancer Res; 1999 Jul; 59(13):3077-83. PubMed ID: 10397248
    [TBL] [Abstract][Full Text] [Related]  

  • 29. XIAP regulates Akt activity and caspase-3-dependent cleavage during cisplatin-induced apoptosis in human ovarian epithelial cancer cells.
    Asselin E; Mills GB; Tsang BK
    Cancer Res; 2001 Mar; 61(5):1862-8. PubMed ID: 11280739
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Down-regulation of X-linked inhibitor of apoptosis protein induces apoptosis in chemoresistant human ovarian cancer cells.
    Sasaki H; Sheng Y; Kotsuji F; Tsang BK
    Cancer Res; 2000 Oct; 60(20):5659-66. PubMed ID: 11059757
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of methylation-silenced genes in colorectal cancer cell lines: genomic screening using oligonucleotide arrays.
    Fukutomi S; Seki N; Koda K; Miyazaki M
    Scand J Gastroenterol; 2007 Dec; 42(12):1486-94. PubMed ID: 17994469
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Over-expression of PTEN sensitizes human ovarian cancer cells to cisplatin-induced apoptosis in a p53-dependent manner.
    Yan X; Fraser M; Qiu Q; Tsang BK
    Gynecol Oncol; 2006 Aug; 102(2):348-55. PubMed ID: 16545436
    [TBL] [Abstract][Full Text] [Related]  

  • 33. UCHL1 loss alters the cell-cycle in metastatic pancreatic neuroendocrine tumors.
    Finnerty BM; Moore MD; Verma A; Aronova A; Huang S; Edwards DP; Chen Z; Seandel M; Scognamiglio T; Du YN; Elemento O; Zarnegar R; Min IM; Fahey TJ
    Endocr Relat Cancer; 2019 Apr; 26(4):411-423. PubMed ID: 30689542
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proapoptotic protein Smac mediates apoptosis in cisplatin-resistant ovarian cancer cells when treated with the anti-tumor agent AT101.
    Hu W; Wang F; Tang J; Liu X; Yuan Z; Nie C; Wei Y
    J Biol Chem; 2012 Jan; 287(1):68-80. PubMed ID: 22052903
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ubiquitin C-terminal hydrolase-L1 has prognostic relevance and is a therapeutic target for high-grade neuroendocrine lung cancers.
    Shimada Y; Kudo Y; Maehara S; Matsubayashi J; Otaki Y; Kajiwara N; Ohira T; Minna JD; Ikeda N
    Cancer Sci; 2020 Feb; 111(2):610-620. PubMed ID: 31845438
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatitis B X-interacting protein promotes cisplatin resistance and regulates CD147 via Sp1 in ovarian cancer.
    Zou W; Ma X; Yang H; Hua W; Chen B; Cai G
    Exp Biol Med (Maywood); 2017 Mar; 242(5):497-504. PubMed ID: 28056551
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA let‑7d‑5p rescues ovarian cancer cell apoptosis and restores chemosensitivity by regulating the p53 signaling pathway via HMGA1.
    Chen YN; Ren CC; Yang L; Nai MM; Xu YM; Zhang F; Liu Y
    Int J Oncol; 2019 May; 54(5):1771-1784. PubMed ID: 30816441
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The p53 upregulated modulator of apoptosis (PUMA) chemosensitizes intrinsically resistant ovarian cancer cells to cisplatin by lowering the threshold set by Bcl-x(L) and Mcl-1.
    Yuan Z; Cao K; Lin C; Li L; Liu HY; Zhao XY; Liu L; Deng HX; Li J; Nie CL; Wei YQ
    Mol Med; 2011; 17(11-12):1262-74. PubMed ID: 21863213
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Chemotherapy resistance induced by interleukin-6 in ovarian cancer cells and its signal transduction pathways].
    Wang Y; Li LZ; Ye L; Niu XL; Liu X; Zhu YQ; Sun WJ; Liang YJ
    Zhonghua Fu Chan Ke Za Zhi; 2010 Sep; 45(9):691-8. PubMed ID: 21092551
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CpG hypermethylation of the UCHL1 gene promoter is associated with pathogenesis and poor prognosis in renal cell carcinoma.
    Kagara I; Enokida H; Kawakami K; Matsuda R; Toki K; Nishimura H; Chiyomaru T; Tatarano S; Itesako T; Kawamoto K; Nishiyama K; Seki N; Nakagawa M
    J Urol; 2008 Jul; 180(1):343-51. PubMed ID: 18499164
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.